You are here

Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip

Last updated on February 23, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Aston Clinton, Bucks, GP22 5LB United Kingdom
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Hip Osteoarthritis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
45 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Diagnosed with osteoarthritis of hip and requiring joint replacement

- Eligible for chronic therapy with an NSAID

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Hip surgery anticipated within 8 calendar weeks after first visit

- Active gastrointestinal disease or recent diagnosis of gastrointestinal ulceration
(within 60 days of first visit)

NCT00174317
Pfizer
Completed
Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Knee Osteoarthritis, Hip Osteoarthritis
NCT00994890
All Genders
Chronic Pain, Hip Osteoarthritis, Knee Osteoarthritis
NCT02528188
All Genders
18+
Years
Multiple Sites
Arthritis, Osteoarthritis, Hip Osteoarthritis
NCT00744471
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now